Rare thrombotic disorder due to a platelet anomaly

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:248368
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Rare thrombotic disorder due to a platelet anomaly is an extremely uncommon blood condition in which the platelets (the small blood cells that help your blood clot) do not work properly, leading to an increased tendency to form dangerous blood clots (thrombosis). Unlike more common clotting disorders that involve problems with clotting proteins in the blood plasma, this condition specifically involves an abnormality in the platelets themselves. Platelets in affected individuals may be overly active or have structural or signaling defects that make them stick together too easily or too often, forming clots in blood vessels where they should not. Blood clots can block blood flow in veins or arteries, potentially causing serious complications such as deep vein thrombosis (clots in the legs), pulmonary embolism (clots traveling to the lungs), stroke, or heart attack. Symptoms can vary widely depending on where clots form and how severe the platelet abnormality is. Some patients may experience repeated clotting events starting at a young age, while others may have milder presentations. Because this is an extremely rare condition, the treatment landscape is limited and largely based on managing symptoms and preventing clot formation. Antiplatelet medications (such as aspirin or clopidogrel) and anticoagulant drugs (blood thinners) are commonly used. Treatment plans are typically individualized based on the specific platelet defect identified and the patient's clinical history. Research into the underlying genetic and molecular causes is ongoing, and management often requires coordination among multiple specialists.

Key symptoms:

Blood clots in the legs (deep vein thrombosis)Blood clots in the lungs (pulmonary embolism)Stroke or mini-stroke symptomsChest pain due to clots in heart vesselsSwelling, pain, or redness in a limbShortness of breathRepeated clotting events at a young ageSkin discoloration over affected veinsHeadaches or vision changes from clots in brain vesselsFatigue and general feeling of being unwellWarmth or tenderness in the affected area

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Rare thrombotic disorder due to a platelet anomaly.

View clinical trials →

No actively recruiting trials found for Rare thrombotic disorder due to a platelet anomaly at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Rare thrombotic disorder due to a platelet anomaly community →

No specialists are currently listed for Rare thrombotic disorder due to a platelet anomaly.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Rare thrombotic disorder due to a platelet anomaly.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Rare thrombotic disorder due to a platelet anomalyForum →

No community posts yet. Be the first to share your experience with Rare thrombotic disorder due to a platelet anomaly.

Start the conversation →

Latest news about Rare thrombotic disorder due to a platelet anomaly

No recent news articles for Rare thrombotic disorder due to a platelet anomaly.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What specific platelet abnormality do I have, and is the exact cause known?,What medications do I need to take, and what are the risks and side effects?,How often will I need blood tests and follow-up appointments?,What are the warning signs of a new blood clot that I should watch for?,Are there activities or situations I should avoid to reduce my clotting risk?,Should my family members be tested for this condition?,Are there any clinical trials or new treatments being studied for my condition?

Common questions about Rare thrombotic disorder due to a platelet anomaly

What is Rare thrombotic disorder due to a platelet anomaly?

Rare thrombotic disorder due to a platelet anomaly is an extremely uncommon blood condition in which the platelets (the small blood cells that help your blood clot) do not work properly, leading to an increased tendency to form dangerous blood clots (thrombosis). Unlike more common clotting disorders that involve problems with clotting proteins in the blood plasma, this condition specifically involves an abnormality in the platelets themselves. Platelets in affected individuals may be overly active or have structural or signaling defects that make them stick together too easily or too often, f